Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab for induction and maintenance of mucosal healing in Crohn's disease in clinical practice
2017-005151-83Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jul 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ustekinumab in Crohn's disease, sponsored by Charité – Universitätsmedizin Berlin. Started Jul 2018; status: completed.
02
Drugs
ustekinumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2017-005151-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005151-83.